Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published as Ann Surg Oncol Early Release 10.1245/ASO.2003.04.020 on November 10, 2003

Annals of Surgical Oncology 10:1191-1196 (2003)
© 2003 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarela, A. I.
Right arrow Articles by Conlon, K. C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarela, A. I.
Right arrow Articles by Conlon, K. C. P.
Related Collections
Right arrow Surgery

ORIGINAL ARTICLES

Metastasis to the Adrenal Gland: The Emerging Role of Laparoscopic Surgery

Abeezar I. Sarela, MB, BS, Ian Murphy, MB, ChB, Daniel G. Coit, MD and Kevin C. P. Conlon, MD

From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

Correspondence: Address correspondence and reprint requests to: Daniel G. Coit, MD, Gastric and Mixed Tumor Service, Memorial Hospital, 1275 York Ave., New York, NY 10021; Fax: 212-717-3400; E-mail: coitd{at}mskcc.org

Background: It is unclear whether resection of clinically isolated metastasis to the adrenal gland improves survival. Also, the role of laparoscopic adrenalectomy (LA) for metastasis is controversial. This study aimed to (1) identify patients who are most likely to have prolonged survival after resection of adrenal metastasis and (2) compare oncological outcomes of LA and open adrenalectomy (OA).

Methods: A retrospective review of 41 patients, who underwent either OA or LA for metastasis to the adrenal gland during 1997–2002 at a single institution, was conducted.

Results: There were 20 women and 21 men, with a median age of 59 years. The most common disease was non-small-cell lung carcinoma (n = 23), followed by renal cell carcinoma (n = 6). With a median follow-up of 16 months, the overall five-year actuarial survival was 29% (median, 28 months). Four patients were actually alive at four years after adrenalectomy. Disease-free interval (DFI) > 6 months was the only significant predictor of improved survival. LA was performed for 11 patients. There was no difference in the incidence of positive resection-margins or survival between patients with OA or LA.

Conclusions: Adrenalectomy for metastasis, with intent to prolong survival, should be offered to patients with favorable tumor biology, such as those with significant DFI. The oncological outcome from LA appears similar to that from OA.

Key Words: Neoplasm recurrence • Secondary • Laparoscopy • Lung neoplasm • Kidney neoplasm




This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
F. J. Collinson, T. K. Lam, W. M. J. Bruijn, J. H. W. de Wilt, M. Lamont, J. F. Thompson, and R. F. Kefford
Long-term Survival and Occasional Regression of Distant Melanoma Metastases after Adrenal Metastasectomy
Ann. Surg. Oncol., June 1, 2008; 15(6): 1741 - 1749.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Q.-Y. Duh
Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis: The Right Thing to Do and the Right Way to Do It
Ann. Surg. Oncol., December 1, 2007; 14(12): 3288 - 3289.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
V. E. Strong, M. D'Angelica, L. Tang, F. Prete, M. Gonen, D. Coit, K. A. Touijer, Y. Fong, and M. F. Brennan
Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis
Ann. Surg. Oncol., December 1, 2007; 14(12): 3392 - 3400.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. T. Adler, E. Mack, and H. Chen
Isolated Adrenal Mass in Patients with a History of Cancer: Remember Pheochromocytoma
Ann. Surg. Oncol., August 1, 2007; 14(8): 2358 - 2362.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
F. L. Greene, K. W. Kercher, H. Nelson, C. M. Teigland, and A.-M. Boller
Minimal Access Cancer Management
CA Cancer J Clin, May 1, 2007; 57(3): 130 - 146.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
I. C. Mitchell and F. E. Nwariaku
Adrenal Masses in the Cancer Patient: Surveillance or Excision
Oncologist, February 1, 2007; 12(2): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
A. Munoz, G. Lopez-Vivanco, J.-M. Mane, R. Fernandez, J. Diaz-Aguirregoitia, M. Saiz, and R. Barcelo
Metastatic Non-Small-Cell Lung Carcinoma Successfully Treated with Pre-operative Chemotherapy and Bilateral Adrenalectomy
Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 731 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
Endocr. Rev., April 1, 2004; 25(2): 309 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Q.-Y. Duh
Resecting Isolated Adrenal Metastasis: Why and How?
Ann. Surg. Oncol., December 1, 2003; 10(10): 1138 - 1139.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.